95-7047. Certain Curable Fluoroelastomer Compositions and Precursors Thereof; Issuance of Limited Exclusion Order and Cease and Desist Order  

  • [Federal Register Volume 60, Number 55 (Wednesday, March 22, 1995)]
    [Notices]
    [Pages 15157-15158]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-7047]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    INTERNATIONAL TRADE COMMISSION
    
    [Investigation No. 337-TA-364]
    
    
    Certain Curable Fluoroelastomer Compositions and Precursors 
    Thereof; Issuance of Limited Exclusion Order and Cease and Desist Order
    
    AGENCY: International Trade Commission.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: Notice is hereby given that the U.S. International Trade 
    Commission has issued a limited exclusion order and a cease and desist 
    order in the above-captioned investigation.
    
    FOR FURTHER INFORMATION CONTACT: Mark D. Kelly, Esq., Office of the 
    General Counsel, U.S. International Trade Commission, 500 E Street, 
    SW., Washington, DC 20436, telephone 202-205-3106.
    
    SUPPLEMENTARY INFORMATION: The authority for the Commission's 
    determinations is contained in section 337 of the Tariff Act of 1930, 
    as amended (19 U.S.C. 1337), and in Sec. 210.58 of the Commission's 
    Interim Rules of Practice and Procedure (19 CFR 210.58).
        The Commission instituted this investigation on March 16, 1994, 
    based upon a complaint filed by Minnesota Mining and Manufacturing 
    Company (``3M'') alleging that Ausimont, S.p.A., of Milan, Italy, and 
    Ausimont U.S.A., Inc., of Morristown, NJ (collectively referred to as 
    ``respondents'' or ``Ausimont'') had violated section 337 in the sale 
    for importation, the importation, and the sale within the United States 
    after importation of certain curable fluoroelastomer compositions and 
    precursors thereof, by reason of infringement of one or more claims of 
    U.S. Letters Patent 4,287,320 (``the '320 patent'') assigned to 3M. 59 
    FR 12344 (March 16, 1994).
        On December 15, 1994, the presiding administrative law judge (ALJ) 
    issued his final initial determination (ID) finding that respondents 
    had violated section 337, based on his findings that (1) the claims in 
    issue of the '320 patent are not invalid; (2) the accused products 
    imported by respondents infringe the claims in issue of the '320 patent 
    under the doctrine of equivalents; and (3) a domestic industry exists. 
    On February 2, 1995, the Commission determined not to review the ALJ's 
    final ID and requested written submissions on the issues of remedy, the 
    public interest, and bonding. 60 FR 7581 (February 8, 1995).
        Submissions on remedy, the public interest, and bonding were 
    received from complainant 3M, respondents, and the Commission 
    investigative attorney (IA). Complainant, respondents, and the IA also 
    filed reply submissions on these issues.
        Having reviewed the record in this investigation, including the 
    written submissions of the parties, the Commission made its 
    determinations on the issues of remedy, the public interest, and 
    bonding. The Commission determined that the appropriate form of relief 
    is a limited exclusion order prohibiting the unlicensed importation of 
    infringing fluoroelastomer compositions or precursors thereof 
    manufactured and/or imported by or on behalf of Ausimont, S.p.A. of 
    Milan, Italy or Ausimont U.S.A, Inc., of Morristown, New Jersey. In 
    addition, the Commission issued a cease and desist order directed to 
    the domestic respondent, Ausimont U.S.A, ordering it to cease and 
    desist from the following activities in the United States: importing, 
    selling, marketing, distributing, offering for sale, or otherwise 
    transferring (except for exportation) in the United States infringing 
    imported curable fluoroelastomer compositions or precursors thereof. 
    The orders apply to any of the affiliated companies, parents, 
    subsidiaries, licensees, contractors, or other related business 
    entities, or their successors or assigns, of the above-named companies.
        The Commission also determined that the public interest factors 
    enumerated in 19 U.S.C. 1337 (d) and (f) do not preclude the issuance 
    of the limited exclusion and cease and desist orders, and that the bond 
    during the Presidential review period shall be in the amount of 48 
    percent of the entered value of the articles in question.
        Copies of the Commission orders, the Commission opinion in support 
    thereof, and all other nonconfidential documents filed in connection 
    with this investigation are or will be available for inspection during 
    official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the 
    Secretary, U.S. International Trade Commission, 500 E Street, SW., 
    Washington, DC 20436, telephone 202-205-2000. Hearing-impaired persons 
    are advised that information on this matter can be obtained by 
    contacting the Commission's TDD terminal on 202-205-1810.
    
        Issued: March 16, 1995.
    
        [[Page 15158]] By order of the Commission.
    Donna R. Koehnke,
    Secretary.
    [FR Doc. 95-7047 Filed 3-21-95; 8:45 am]
    BILLING CODE 7020-02-P
    
    

Document Information

Published:
03/22/1995
Department:
International Trade Commission
Entry Type:
Notice
Action:
Notice.
Document Number:
95-7047
Pages:
15157-15158 (2 pages)
Docket Numbers:
Investigation No. 337-TA-364
PDF File:
95-7047.pdf